EE200000193A - Kasvuhormoonide sekreteerimist stimuleerivate ühendite valmistamise protsess - Google Patents

Kasvuhormoonide sekreteerimist stimuleerivate ühendite valmistamise protsess

Info

Publication number
EE200000193A
EE200000193A EEP200000193A EEP200000193A EE200000193A EE 200000193 A EE200000193 A EE 200000193A EE P200000193 A EEP200000193 A EE P200000193A EE P200000193 A EEP200000193 A EE P200000193A EE 200000193 A EE200000193 A EE 200000193A
Authority
EE
Estonia
Prior art keywords
compounds
preparation
growth hormone
hormone secretion
stimulate growth
Prior art date
Application number
EEP200000193A
Other languages
English (en)
Inventor
Kwok-Fung Chiu Charles
Nathaniel Meltz Clifford
James Post Ronald
Robert Busch Frank
Robert Rose Peter
Original Assignee
Pfizer Products Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Products Inc. filed Critical Pfizer Products Inc.
Publication of EE200000193A publication Critical patent/EE200000193A/et

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
    • C07K5/0202—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -NH-X-X-C(=0)-, X being an optionally substituted carbon atom or a heteroatom, e.g. beta-amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/02—Drugs for disorders of the endocrine system of the hypothalamic hormones, e.g. TRH, GnRH, CRH, GRH, somatostatin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06191—Dipeptides containing heteroatoms different from O, S, or N
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Peptides Or Proteins (AREA)
EEP200000193A 1999-02-26 2000-02-28 Kasvuhormoonide sekreteerimist stimuleerivate ühendite valmistamise protsess EE200000193A (et)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US12274599P 1999-02-26 1999-02-26

Publications (1)

Publication Number Publication Date
EE200000193A true EE200000193A (et) 2000-10-16

Family

ID=22404505

Family Applications (1)

Application Number Title Priority Date Filing Date
EEP200000193A EE200000193A (et) 1999-02-26 2000-02-28 Kasvuhormoonide sekreteerimist stimuleerivate ühendite valmistamise protsess

Country Status (44)

Country Link
US (2) US6541634B2 (et)
EP (2) EP1031575B1 (et)
JP (3) JP3437813B2 (et)
KR (2) KR100372063B1 (et)
CN (3) CN1137891C (et)
AP (1) AP1221A (et)
AR (2) AR029617A1 (et)
AT (1) ATE277944T1 (et)
AU (1) AU764122B2 (et)
BG (1) BG104175A (et)
BR (2) BRPI0000967B8 (et)
CA (1) CA2299495C (et)
CO (1) CO5160252A1 (et)
DE (1) DE60014212T2 (et)
DK (1) DK1031575T3 (et)
DZ (1) DZ3018A1 (et)
EA (1) EA003218B1 (et)
EE (1) EE200000193A (et)
ES (1) ES2226712T3 (et)
GT (1) GT200000018A (et)
HK (1) HK1030219A1 (et)
HN (1) HN2000000021A (et)
HR (1) HRP20000103A2 (et)
HU (1) HUP0000907A3 (et)
ID (1) ID24861A (et)
IL (2) IL134599A (et)
IN (1) IN192352B (et)
IS (1) IS5380A (et)
MA (1) MA25072A1 (et)
NO (1) NO20000965L (et)
NZ (1) NZ503062A (et)
OA (1) OA11325A (et)
PA (1) PA8491201A1 (et)
PE (1) PE20001550A1 (et)
PL (1) PL338628A1 (et)
PT (1) PT1031575E (et)
SG (1) SG90096A1 (et)
SI (1) SI1031575T1 (et)
SK (1) SK284982B6 (et)
TN (1) TNSN00035A1 (et)
TR (1) TR200000536A2 (et)
TW (2) TWI286142B (et)
UA (1) UA70306C2 (et)
ZA (1) ZA200000888B (et)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1132388A3 (en) * 2000-03-09 2004-03-03 Pfizer Products Inc. Hexahydropyrazolo[4,3-c]pyridine metabolites
AU6497701A (en) 2000-05-30 2001-12-11 Merck & Co Inc Melanocortin receptor agonists
WO2004103983A1 (en) * 2003-05-26 2004-12-02 Biocon Limited Process for the preparation of s(+)-2-ethoxy-4-[n-{1-(2-piperidinophelyl)-3-methyl-1- butyl} aminocarbonylmethyl]benzoic acid derivatives
WO2005027913A1 (en) * 2003-09-19 2005-03-31 Pfizer Products Inc. Pharmaceutical compositions and methods comprising combinations of 2-alkylidene-19-nor-vitamin d derivatives and a growth hormone secretagogue
US9117477B2 (en) 2013-05-08 2015-08-25 HGST Netherlands B.V. Perpendicular magnetic recording media having novel seed layer
WO2014192294A1 (en) * 2013-05-28 2014-12-04 Raqualia Pharma Inc. Polymorph forms
CN109320515A (zh) * 2018-11-22 2019-02-12 常州大学 一种Capromorelin手性中间体的不对称合成方法

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8610980D0 (en) 1986-05-06 1986-06-11 Ici America Inc Heterocyclic fused tricyclic compounds
GB8901423D0 (en) 1989-01-23 1989-03-15 Fujisawa Pharmaceutical Co Pyrazolopyridine compound and processes for preparation thereof
US5578593A (en) 1992-12-11 1996-11-26 Merck & Co., Inc. Spiro piperidines and homologs promote release of growth hormone
CZ134296A3 (en) 1993-11-09 1996-12-11 Merck & Co Inc Piperidine, pyrrolidine and hexahydro-1h-azepine derivatives, process of their preparation and pharmaceutical compositions containing thereof
US5609150A (en) 1995-04-18 1997-03-11 Maged; Jeffrey M. Method for dilating respiratory passages
TW432073B (en) 1995-12-28 2001-05-01 Pfizer Pyrazolopyridine compounds
AU2334097A (en) 1996-03-21 1997-10-10 Merck & Co., Inc. 4-spiroindoline piperidines promote release of growth hormone
WO1997036873A1 (en) 1996-04-03 1997-10-09 Merck & Co., Inc. Piperidines, pyrrolidines and hexahydro-1h-azepines promote release of growth hormone
UA64751C2 (uk) 1997-06-25 2004-03-15 Пфайзер Продактс Інк. Спосіб лікування інсулінової толерантності речовинами, які посилюють секрецію гормону росту (варіанти) та фармацевтична композиція (варіанти)
AU7445498A (en) 1997-06-25 1999-01-04 Pfizer Inc. Dipeptide derivatives as growth hormone secretagogues
UA53716C2 (uk) 1997-06-25 2003-02-17 Пфайзер Продактс Інк. Тартратна сіль заміщеного дипептиду, спосіб її одержання, проміжні сполуки та спосіб їх одержання, фармацевтична композиція (варіанти), спосіб підвищення рівнів ендогенного гормону росту та спосіб лікування або профілактики захворювань (варіанти)

Also Published As

Publication number Publication date
CO5160252A1 (es) 2002-05-30
IL134599A (en) 2006-12-10
HUP0000907A2 (en) 2001-03-28
MA25072A1 (fr) 2000-10-01
IL157103A (en) 2007-07-24
UA70306C2 (en) 2004-10-15
EP1449842A1 (en) 2004-08-25
IN192352B (et) 2004-04-10
IS5380A (is) 2000-08-27
CN1837205A (zh) 2006-09-27
GT200000018A (es) 2001-08-16
KR20020065455A (ko) 2002-08-13
JP2003261565A (ja) 2003-09-19
TWI286142B (en) 2007-09-01
KR100361783B1 (ko) 2002-11-22
JP4051314B2 (ja) 2008-02-20
ES2226712T3 (es) 2005-04-01
SK284982B6 (sk) 2006-03-02
EA200000172A3 (ru) 2000-10-30
KR20010006698A (ko) 2001-01-26
US6541634B2 (en) 2003-04-01
BRPI0017522A2 (et) 2009-12-22
CA2299495C (en) 2010-06-15
SG90096A1 (en) 2002-07-23
PE20001550A1 (es) 2001-01-11
BRPI0000967B1 (pt) 2012-06-12
JP3437813B2 (ja) 2003-08-18
US20030158414A1 (en) 2003-08-21
HK1030219A1 (en) 2001-04-27
PL338628A1 (en) 2000-08-28
CA2299495A1 (en) 2000-08-26
TW200718702A (en) 2007-05-16
DE60014212T2 (de) 2005-12-15
ATE277944T1 (de) 2004-10-15
AR053722A2 (es) 2007-05-16
TNSN00035A1 (fr) 2005-11-10
BRPI0017522B8 (pt) 2021-05-25
ID24861A (id) 2000-08-31
OA11325A (en) 2003-10-27
AP2000001754A0 (en) 2000-03-31
US20020002283A1 (en) 2002-01-03
US6673929B2 (en) 2004-01-06
PT1031575E (pt) 2004-11-30
SK2302000A3 (en) 2000-11-07
BG104175A (bg) 2000-12-29
AP1221A (en) 2003-11-03
IL134599A0 (en) 2001-04-30
DK1031575T3 (da) 2005-01-03
ZA200000888B (en) 2001-08-23
BRPI0017522B1 (pt) 2013-09-24
CN1270960A (zh) 2000-10-25
TR200000536A2 (tr) 2000-09-21
EP1031575B1 (en) 2004-09-29
IL157103A0 (en) 2004-02-08
AU764122B2 (en) 2003-08-07
DE60014212D1 (de) 2004-11-04
NZ503062A (en) 2001-07-27
EP1031575A1 (en) 2000-08-30
KR100372063B1 (ko) 2003-02-14
CN1515570A (zh) 2004-07-28
HN2000000021A (es) 2001-02-02
AR029617A1 (es) 2003-07-10
HUP0000907A3 (en) 2001-05-28
JP2000247974A (ja) 2000-09-12
HU0000907D0 (en) 2000-04-28
PA8491201A1 (es) 2001-04-30
AU1947100A (en) 2000-08-31
BRPI0000967A (pt) 2001-09-11
SI1031575T1 (en) 2005-02-28
JP2003327585A (ja) 2003-11-19
EA200000172A2 (ru) 2000-08-28
CN1137891C (zh) 2004-02-11
NO20000965D0 (no) 2000-02-25
HRP20000103A2 (en) 2001-04-30
NO20000965L (no) 2000-08-28
DZ3018A1 (fr) 2004-03-20
EA003218B1 (ru) 2003-02-27
BRPI0000967B8 (pt) 2021-12-07

Similar Documents

Publication Publication Date Title
ATE302181T1 (de) Verbindungen zur stimulation der sekretion von wachstumshormonen
IS4758A (is) Efnasambönd sem örva seyti vaxtarhormóna
FI20000564A (fi) Menetelmä nanolaminaattien valmistamiseksi
ATE344027T1 (de) Fettsäurederivat zur behandlung von externen sekretionsstörungen
ATE320257T1 (de) (s,s)-reboxetine zur behandlung chronischer schmerzen
DE60019556D1 (de) 2-amino-benzoxazinonderivate zur behandlung von fettleibigkeit
PL338883A1 (en) Growth hormone secretion stimulating compounds
PL344831A1 (en) Use of diazepins for preparing medicines for treating pathological conditions or diseases involving one of the growth hormone release inhibiting factor receptors
DE60019555D1 (de) 2-oxy-benzoxazinonderivate zur behandlung von fettleibigkeit
ATE375996T1 (de) Sekretionsfordermittel fur wachtumshormon
EE200000193A (et) Kasvuhormoonide sekreteerimist stimuleerivate ühendite valmistamise protsess
NO20014848L (no) Fremgangsmåte for anvendelse av emamectin for behandling av fiskeparasitter
PL351088A1 (en) Process for the preparation of substituted pyrimidines
DE50009813D1 (de) Kombinationpräparat zur behandlung von sexueller dysfunktion
NO20005216D0 (no) Sammensetning for behandling av eksterne sekresjonssykdommer unntatt hypolakrimasjon
GB0106565D0 (en) Growth hormone treatment
IL138691A (en) Process for the preparation of 3-acyl-indoles
HUP0202865A3 (en) Process for the preparation of 2-cyanopyridines
EP1142898A4 (en) PROCESS FOR THE PREPARATION OF PHOSPHONITE COMPOUNDS
GB9904252D0 (en) Composition for the treatment of pain
NO20020328D0 (no) Fremgangsmåte for fremstilling av 4-cyano-2-aminometyltiazol
NO20020327D0 (no) Fremgangsmåte for fremstilling av 2-aminometyl-4-cyano-tiazol
EE200200053A (et) Isoretinoiini valmistamise protsess
FI19992363A (fi) Menetelmä beta-jononin valmistamiseksi
HUP0201518A2 (en) Process for the preparation of tetrafluorohalogenbenzenes